EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Chemotherapy induces or increases expression of multidrug resistance-associated protein in malignant melanoma cells



Chemotherapy induces or increases expression of multidrug resistance-associated protein in malignant melanoma cells



British Journal of Dermatology 144(4): 745-750, April



Background: Human malignant melanoma is notoriously resistant to chemotherapeutic agents. Melanoma-derived cell lines are often markedly chemoresistant, suggesting that cellular mechanisms mediate generation of the multidrug resistance (MDR) phenotype. This phenotype is often due to P-glycoprotein (Pgp) and the MDR-associated protein (MRP), which are drug transporter proteins associated with resistance to a broad spectrum of lipophilic drugs. Objectives: To determine the relationships between the expression of the MDR gene MDR-1 (the product of which is Pgp) or the MRP gene, and clinical chemoresistance of malignant melanoma. Methods: We examined changes in the expression of MDR-1 and MRP genes at the mRNA level before and after chemotherapy by reverse transcription-polymerase chain reaction (RT-PCR) analysis using formalin-fixed, paraffin-embedded sections of 18 specimens taken from eight melanoma patients. mRNA expression of the MDR-1 and MRP gene-specific PCR products was quantitatively determined by densitometry and compared with that of an internal standard (beta-actin). Results: Five of seven primary melanomas were found to express the MRP gene to a certain extent even before chemotherapy. After first and second courses of chemotherapy, six patients had an increased ratio of MRP mRNA to beta-actin mRNA compared with the prechemotherapy levels in the same patients. None of the cases of melanoma expressed MDR-1. Conclusions: These results suggest that a significant mRNA level of MRP gene was intrinsically present in malignant melanoma even before exposure to chemotherapeutic drugs and increased in its expression after chemotherapy, suggesting that MRP plays a part in increasing the chemoresistance of malignant melanoma during chemotherapy.

(PDF emailed within 0-6 h: $19.90)

Accession: 010314276

Download citation: RISBibTeXText

PMID: 11298532

DOI: 10.1046/j.1365-2133.2001.04129.x



Related references

Correlation of expression levels of multidrug resistance gene 1 (mdr1) mRNA, multidrug resistance-associated protein (MRP), amd P-glycoprotein (P-gp) with chemotherapy efficacy in malignant lymphomas. Zhonghua Yi Xue Za Zhi 82(17): 1177-1179, 2002

Expression of multidrug resistance proteins P-glycoprotein, multidrug resistance protein 1, breast cancer resistance protein and lung resistance related protein in locally advanced bladder cancer treated with neoadjuvant chemotherapy: biological and clinical implications. Journal of Urology 170(4 Pt 1): 1383-1387, 2003

Glycolaldehyde induces cytotoxicity and increases glutathione and multidrug-resistance-associated protein levels in Schwann cells. Biological & Pharmaceutical Bulletin 36(7): 1111-1117, 2013

Technetium-99m-sestamethoxyisobutylisonitrile scan as a predictor of chemotherapy response in malignant lymphomas compared with P-glycoprotein expression, multidrug resistance-related protein expression and other prognosis factors. British Journal of Haematology 113(2): 369-374, 2001

Conjugated bilirubin induces multidrug resistance-associated protein 2 mRNA expression and in vivo cisplatin resistance in rat hepatoma AH66 cells. Anticancer Research 23(6c): 4781-4787, 2004

Inhibition of multidrug resistance-associated protein expression in neuroblastoma cells induces spontaneous differentiation, apoptosis and reduced Bcl-2 expression. Proceedings of the American Association for Cancer Research Annual Meeting 40: 224, March, 1999

Multidrug resistance correlates with overexpression of Muc4 but inversely with P-glycoprotein and multidrug resistance related protein in transfected human melanoma cells. Biochemical Pharmacology 65(9): 1419-1425, 2003

Using technetium-99m-tetrofosmin scan to predict chemotherapy response of malignant lymphomas, compared with P-glycoprotein and multidrug resistance related protein expression. Oncology Reports 9(2): 307-312, 2002

Expression and function of multidrug resistance protein 1 and multidrug resistance-associated protein 1 in lung dendritic cells from aging mice. Journals of Gerontology. Series A, Biological Sciences and Medical Sciences 67(10): 1049-1055, 2012

Expression of multidrug resistance 1 (MDR1), multidrug resistance-related protein 1 (MRP1), lung resistance protein (LRP), and breast cancer resistance protein (BCRP) genes and clinical outcome in childhood acute lymphoblastic leukemia. International Journal of Hematology 86(2): 166-173, 2007

Intrinsic multidrug resistance-associated protein in human malignant melanoma cell lines. European Journal of Cancer 32A(SUPPL 1): S2, 1996

P-glycoprotein and multidrug resistance-associated protein mediate specific patterns of multidrug resistance in malignant glioma cell lines, but not in primary glioma cells. Brain Pathology 13(4): 482-494, 2003

Expression of multidrug resistance-associated protein and multidrug resistance gene on blast cells with acute leukemia and its relationship with drug sensitivity and clinical outcome. Experimental Hematology (Charlottesville) 24(9): 1080, 1996